“WHO’s decision is a vote for evidence-based policy-making, which will save money and harm,” said Fiona Godlee, The BMJ‘s editor in chief.
Tamiflu was originally added to the WHO’s list of essential medicines in 2009 but new evidence has since “reduced the previously estimated magnitude of effect of oseltamivir on relevant clinical outcomes,” according to the 2017 list update.
Now, the WHO recommends the use of Tamiflu for the severely ill with confirmed or suspected influenza virus infection in the hospital.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
